Literature DB >> 22447965

Pulmonary complications of sickle cell disease.

Andrew C Miller1, Mark T Gladwin.   

Abstract

Sickle cell disease (SCD) is a common monogenetic disorder with high associated morbidity and mortality. The pulmonary complications of SCD are of particular importance, as acute chest syndrome and pulmonary hypertension have the highest associated mortality rates within this population. This article reviews the pathophysiology, diagnosis, and treatment of clinically significant pulmonary manifestations of SCD, including acute chest syndrome, asthma, and pulmonary hypertension in adult and pediatric patients. Clinicians should be vigilant in screening and treating such comorbidities to improve patient outcomes.

Entities:  

Mesh:

Year:  2012        PMID: 22447965      PMCID: PMC3373067          DOI: 10.1164/rccm.201111-2082CI

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  110 in total

Review 1.  Pulmonary complications of hemoglobinopathies.

Authors:  Rekha Vij; Roberto F Machado
Journal:  Chest       Date:  2010-10       Impact factor: 9.410

Review 2.  Pulmonary hypertension associated with sickle cell disease: pathophysiology and rationale for treatment.

Authors:  Raymond L Benza
Journal:  Lung       Date:  2008-05-10       Impact factor: 2.584

Review 3.  Pathogenesis and treatment of sickle cell disease.

Authors:  H F Bunn
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

4.  Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies.

Authors:  Giorgio Derchi; Gian Luca Forni; Francesco Formisano; Maria Domenica Cappellini; Renzo Galanello; Giandomenico D'Ascola; Patrizio Bina; Carmelo Magnano; Martina Lamagna
Journal:  Haematologica       Date:  2005-04       Impact factor: 9.941

5.  Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.

Authors:  E P Vichinsky; L D Neumayr; A N Earles; R Williams; E T Lennette; D Dean; B Nickerson; E Orringer; V McKie; R Bellevue; C Daeschner; E A Manci
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

6.  Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease.

Authors:  Caterina P Minniti; Roberto F Machado; Wynona A Coles; Vandana Sachdev; Mark T Gladwin; Gregory J Kato
Journal:  Br J Haematol       Date:  2009-09-22       Impact factor: 6.998

7.  Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission.

Authors:  Amy Sobota; Dionne A Graham; Matthew M Heeney; Ellis J Neufeld
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

8.  Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease.

Authors:  James G Taylor; Diana Ackah; Crystal Cobb; Nick Orr; Melanie J Percy; Vandana Sachdev; Roberto Machado; Oswaldo Castro; Gregory J Kato; Stephen J Chanock; Mark T Gladwin
Journal:  Am J Hematol       Date:  2008-01       Impact factor: 10.047

9.  Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

Authors:  G E D'Alonzo; R J Barst; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; J T Kernis
Journal:  Ann Intern Med       Date:  1991-09-01       Impact factor: 25.391

10.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

View more
  47 in total

1.  The sickle cell mouse lung: proinflammatory and primed for allergic inflammation.

Authors:  Biree Andemariam; Alexander J Adami; Anurag Singh; Jeffrey T McNamara; Eric R Secor; Linda A Guernsey; Roger S Thrall
Journal:  Transl Res       Date:  2015-03-16       Impact factor: 7.012

2.  Asthma Screening in Pediatric Sickle Cell Disease: A Clinic-Based Program Using Questionnaires and Spirometry.

Authors:  Sara C Sadreameli; Rachel O Alade; Peter J Mogayzel; Sharon McGrath-Morrow; John J Strouse
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2017-12-01       Impact factor: 1.349

3.  Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli.

Authors:  Margaret F Bennewitz; Maritza A Jimenez; Ravi Vats; Egemen Tutuncuoglu; Jude Jonassaint; Gregory J Kato; Mark T Gladwin; Prithu Sundd
Journal:  JCI Insight       Date:  2017-01-12

4.  Association between pulmonary function and cardiac enzymes in sickle cell disease.

Authors:  Charles Antwi-Boasiako; Michael M Asare; Ibrahim Baba; Alfred Doku; Kevin Adutwum-Ofosu; Charles Hayfron-Benjamin; Chamila P Asare; Robert Aryee; Gifty Boatemaah Dankwah; John Ahenkorah
Journal:  Am J Blood Res       Date:  2021-04-15

5.  Exosomes contribute to endothelial integrity and acute chest syndrome risk: Preliminary findings.

Authors:  Gabrielle Lapping-Carr; Abdelnaby Khalyfa; Stephanie Rangel; Wendy Darlington; Eric C Beyer; Radhika Peddinti; John M Cunningham; David Gozal
Journal:  Pediatr Pulmonol       Date:  2017-05-09

6.  Application of an Asthma Screening Questionnaire in Children with Sickle Cell Disease.

Authors:  Aravind Yadav; Fernando F Corrales-Medina; James M Stark; S Shahrukh Hashmi; Mary P Carroll; Keely G Smith; Kristen M Meulmester; Deborah L Brown; Cindy Jon; Ricardo A Mosquera
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2015-09-01       Impact factor: 1.349

Review 7.  Review: Hemodynamic Characteristics and Outcomes of Sickle Cell Disease Associated Pulmonary Hypertension.

Authors:  Alem Mehari; Alvin V Thomas; Alicia N Thomas; Mark S Johnson
Journal:  Ethn Dis       Date:  2016-10-20       Impact factor: 1.847

8.  Exhaled nitric oxide: Not associated with asthma, symptoms, or spirometry in children with sickle cell anemia.

Authors:  Robyn T Cohen; Mark Rodeghier; Fenella J Kirkham; Carol L Rosen; Jane Kirkby; Michael R DeBaun; Robert C Strunk
Journal:  J Allergy Clin Immunol       Date:  2016-08-09       Impact factor: 10.793

9.  Gene-centric association study of acute chest syndrome and painful crisis in sickle cell disease patients.

Authors:  Geneviève Galarneau; Sean Coady; Melanie E Garrett; Neal Jeffries; Mona Puggal; Dina Paltoo; Karen Soldano; Antonio Guasch; Allison E Ashley-Koch; Marilyn J Telen; Abdullah Kutlar; Guillaume Lettre; George J Papanicolaou
Journal:  Blood       Date:  2013-05-29       Impact factor: 22.113

Review 10.  Pathophysiology and recent therapeutic insights of sickle cell disease.

Authors:  Firdosh Shah; Mitesh Dwivedi
Journal:  Ann Hematol       Date:  2020-03-10       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.